Recombinant Activated Factor VIIa Treatment for Refractory Hemorrhage in Infants

OBJECTIVE: Report clinical response to recombinant factor VIIa in a cohort of critically ill infants. STUDY DESIGN: We identified all infants who received factor VIIa in the Duke Neonatal Intensive Care Unit between January 2005 and July 2008. Hematologic data and volume of blood transfusions before...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Dang, Chi N, Katakam, Lakshmi I, Smith, P Brian, Cotten, C Michael, Goldberg, Ronald N, Chandler, Nicole, Thornburg, Courtney D, Bidegain, Margarita
Формат: Artigo
Язык:Inglês
Опубликовано: 2010
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2972386/
https://ncbi.nlm.nih.gov/pubmed/20671714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jp.2010.85
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы